Related Experiment Videos
[Susceptibility of community-acquired pneumonia pathogens to azithromycin]
S D Mitrokhin1, O N Zaĭtseva, T D Konstantinova
1Central Clinical Hospital, Moscow.
Abstract:
Two hundred and sixty eight microbial strains were tested for their antibiotic susceptibility. Azithromycin (sumamed) was shown to have an efficient inhibitory action on pneumococci, streptococci and hemophilic bacilli. Doxycycline and gentamicin were not sufficiently active against gram-positive cocci, the same as trimethoprime/sulfamethoxazole which was equally not sufficiently active against hemophilic bacilli. Adequate therapy of bronchopulmonary diseases requires the pathogen antibioticograms.
Insights
Azithromycin effectively inhibited key respiratory pathogens like pneumococci and streptococci. Other antibiotics showed limited activity, highlighting the need for pathogen-specific antibiotic testing in bronchopulmonary disease treatment.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Bronchopulmonary diseases are frequently caused by bacterial infections.
- Effective treatment relies on understanding pathogen susceptibility to antibiotics.
- Empirical antibiotic therapy may be suboptimal without pathogen identification.
Purpose of the Study:
- To evaluate the in vitro antibiotic susceptibility of various microbial strains.
- To determine the efficacy of specific antibiotics against common respiratory pathogens.
- To inform optimal therapeutic strategies for bronchopulmonary infections.
Main Methods:
- Testing of 268 microbial strains for antibiotic susceptibility.
- Assessment of inhibitory action of Azithromycin, Doxycycline, Gentamicin, and Trimethoprime/Sulfamethoxazole.
- Focus on activity against pneumococci, streptococci, hemophilic bacilli, and gram-positive cocci.
Main Results:
- Azithromycin demonstrated significant inhibitory activity against pneumococci, streptococci, and hemophilic bacilli.
- Doxycycline and Gentamicin showed insufficient activity against gram-positive cocci.
- Trimethoprime/Sulfamethoxazole exhibited inadequate activity against hemophilic bacilli.
Conclusions:
- Azithromycin is a potentially effective agent for treating infections caused by susceptible strains of pneumococci, streptococci, and hemophilic bacilli.
- The limited efficacy of Doxycycline, Gentamicin, and Trimethoprime/Sulfamethoxazole against specific bacterial groups underscores treatment challenges.
- Pathogen-specific antibioticograms are crucial for guiding adequate and effective therapy in bronchopulmonary diseases.